首页> 外文期刊>Journal of gastroenterology and hepatology >Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma.
【24h】

Sustained low hepatitis B viral load predicts good outcome after curative resection in patients with hepatocellular carcinoma.

机译:持续低的乙肝病毒载量预示肝癌患者根治性切除后的良好结局。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIM: Little is known about the role of hepatitis B virus (HBV) factors in the long-term prognosis of hepatocellular carcinoma (HCC) after resection. The objective of the present study was to identify the changing patterns of HBV levels and its effect on outcome after resection. METHODS: This study recruited 188 patients with HBV-related HCC who underwent curative resection. Among the 188 patients, 115 were alive without recurrence at 12 months, and had serial measurements of viral levels. RESULTS: The mean age was 53 years and the mean follow-up period was 48.5 months. With multivariate analysis, tumor size > 5 cm (P = 0.047), Child-Pugh class B (P = 0.017), vascular invasion (P = 0.028), and HBV DNA > 10(4) copies/mL at the time of resection (P = 0.003) were independently predictive of HCC recurrence for the entire population. For the 115 patients with serial measurements of viral levels, tumor size > 5 cm, HBV DNA > 10(4) copies/mL at resection, and the absence of sustained HBV DNA level < 10(4) copies/mL, the presence of cirrhosis, and elevated aminotransferase levels (> 40 IU/L) were marginally or significantly associated with HCC recurrence and overall survival. However, on multivariate analysis, sustained HBV DNA level < 10(4) copies/mL was the only factor for both low recurrence (P = 0.002; odds ratio [OR] 3.13; 95% confidence interval [CI] 1.55-6.35) and longer survival (P = 0.002; OR 3.76; 95% CI 1.61-8.78). CONCLUSIONS: A high HBV replication state is among the most important predictors of adverse outcome after resection of HBV-related HCC. The sustained suppression of HBV below 10(4) copies/mL is a strong protective factor for long-term recurrence-free and overall survival.
机译:背景与目的:乙肝病毒(HBV)因子在切除术后肝细胞癌(HCC)的长期预后中的作用知之甚少。本研究的目的是确定切除后HBV水平的变化模式及其对预后的影响。方法:本研究招募了接受根治性切除术的188例HBV相关性HCC患者。在188例患者中,有115例在12个月时还没有复发,并且还进行了一系列病毒水平检测。结果:平均年龄为53岁,平均随访期为48.5个月。通过多变量分析,切除时肿瘤大小> 5 cm(P = 0.047),Child-Pugh B级(P = 0.017),血管侵犯(P = 0.028)和HBV DNA> 10(4)拷贝/ mL (P = 0.003)独立预测整个人群的HCC复发。对于115例连续测量病毒水平的患者,切除时肿瘤大小> 5 cm,HBV DNA> 10(4)拷贝/ mL,并且持续的HBV DNA水平<10(4)拷贝/ mL不存在时,存在肝硬化和转氨酶水平升高(> 40 IU / L)与HCC复发和总生存率有少量或显着相关。然而,在多变量分析中,持续的HBV DNA水平<10(4)拷贝/ mL是导致低复发率的唯一因素(P = 0.002;优势比[OR] 3.13; 95%置信区间[CI] 1.55-6.35)和生存期更长(P = 0.002; OR 3.76; 95%CI 1.61-8.78)。结论:高水平的乙肝病毒复制状态是切除乙肝相关肝癌后不良结局的最重要预测指标之一。低于10(4)拷贝/ mL的HBV持续抑制是长期无复发和总体生存的强大保护因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号